Aytu volume Combine warren buffet style investing into shorted stocks and you have an explosion of green dildos. Find the latest Aytu BioPharma, Inc. Our novel therapeutics enhance the lives of patients living with major depressive disorder (MDD) and attention deficit/hyperactivity disorder (ADHD). Find the latest Aytu BioPharma, Inc. Get the latest Aytu Biopharma Inc (AYTU) stock price, news, analysis, and research in Stockscan. (LON:0A8M) stock price with financials, statistics, dividends, charts and more. As of October 31st, traders have sold 499,690 shares of AYTU short. Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats Sep 23, 2025 · Aytu BioPharma Inc. 03M with 9,911,913 shares outstanding. Common Stock (AYTU) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Dec 10, 2020 · --Aytu BioScience, Inc. Its novel design uniquely serves patients and health care providers navigating their complex treatment journeys. The company’s market capitalization stands at $12. AYTU is the former Neos Pharma, which merged with AYTU in a reverse merger in 2021. View AYTU Options and Max Pain. The short sale volume percent is down -18% compare to Sep 24, 2025. AYTU is being discussed heatedly; come and join tens of millions investors to discuss AYTU Feb 15, 2025 · According to some industry analysts covering Aytu BioPharma, breakeven is near. , a commercial-stage Webull offers Aytu Biopharma Inc (AYTU) historical stock prices, in-depth market analysis, NASDAQ: AYTU real-time stock quote data, in-depth charts. ) five Source: Alar: Kannada-English corpus context information Kannada is a Dravidian language (as opposed to the Indo-European language family) mainly spoken in the southwestern region of India. 100% free, no signups. Tons of financial metrics for serious investors. Get the latest Aytu Biopharma Inc (AYTU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 53%. İnsan Kaynakları Şirketimizdeki açık pozisyonlar hakkında bilgi almak ve iş başvurusunda bulunmak için bize CV'nizi gönderebilirsiniz. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$5. Discover full insights on StockIntent. Jun 25, 2025 · DENVER, CO / ACCESS Newswire / June 25, 2025 / Aytu BioPharma, Inc. (AYTU) stock, including real-time price, chart, key statistics, news, and more. There has been approximately $54,866,223 of trading volume. intraday tips for today and tomorrow Nov 11, 2025 · A detailed overview of Aytu BioPharma, Inc. Get Aytu Biopharma Inc (AYTU:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. (AYTU) stock news and headlines to help you in your trading and investing decisions. Analyse Aytu Biopharma Inc 's stock charts with over 30 different indicators - CSIMarket Aytu BioPharma Inc technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis 3 days ago · View AYTU price history, and other historical data. 24, the stock is trading +11. Companies that are shorted to oblivion but have a bullish case, for a potential short squeeze. Oct 10, 2025 · AYTU | Complete Aytu BioPharma Inc. Oct 3, 2025 · AYTU Stock Summary AYTU BioPharma, Inc. Volume spikes and late-day news helped Company profile for Aytu BioPharma Inc. Daily short sale volume for stock ticker AYTU is 48% on Sep 25, 2025. AYTU - Aytu BioPharma Inc - Stock screener for investors and traders, financial visualizations. View live Aytu BioPharma, Inc. Get AYTU carts now. 24. Common Stock (NASDAQ:AYTU) stock price today is $1. What Were Price & Volume?How Did The Day Rank?Which Quartile Did The Day's Price & Volume Land?How Were Monthly Price & Volume Averages?What Were Monthly %Ch Nov 14, 2024 · Aytu BioPharma Inc (AYTU) achieves its first-ever positive net income, while expanding its ADHD and pediatric portfolios amidst revenue challenges. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. 6 days ago · AYTU Short Interest - Frequently Asked Questions What is Aytu BioPharma's current short interest? Short interest is the volume of Aytu BioPharma shares that have been sold short but have not yet been covered or closed out. AYTU Off Exchange & Dark Pool Summary Today's Off Exchange & Dark Pool volume is 14,487, which is 53. 49, up 2. including key executives, insider trading, ownership, revenue and average growth rates. AYTU'ya Katılın Aşağıdaki bölümlerden bayi başvurusu yapabilir, açık iş poziyonlarını görebilir ve ürün kataloglarımıza ulaşabilirsiniz. 92, and today's volume is 102,491. See volume history, peer comparisons, and what this means for investors — updated live. Our unique prescription therapeutics help patients lead healthier and more fulfilling lives, with a distinct focus on complex central nervous system (CNS) conditions. (AYTU) rose 7. As of the latest close, Aytu BioPharma traded at $2. Nov 11, 2025 · See the latest Aytu BioPharma Inc stock price (AYTU:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Our CNS product portfolio addresses major depressive disorder (MDD) and attention deficit View historical prices for Aytu Biopharma (AYTU) including open, high, low, close (OHLC), volume, volume weighted average price (VWAP), option volume, implied volatility and more. 373 Inverness Parkway, Suite 206 Englewood, CO 80112 USA +1 (855) AYTU BIO (+1 855-298-8246) Discover real-time Aytu BioPharma, Inc. With an established portfolio in CNS and specialty medicines, we will continue to acquire and commercialize novel products to help people lead better lives, with a distinct focus on psychiatric conditions. com. 0% above its intraday low and 0. The 30 day average volume is 240,140. The absence of large institutional blocks suggests this was a “casualty of momentum,” not a strategic bet. You’ll never pay more than […] Sep 11, 2021 · Aytu (ಅಯ್ತು):— [noun] (pl. 6 days ago · Aytu Bioscience has increased volume and follows the last lift in the price. 2 days ago · Should You Buy or Sell Aytu BioPharma Stock? Get The Latest AYTU Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Nov 11, 2025 · AYTU / Aytu BioPharma, Inc. 538% today. 05%. We ensure access to our medicines by thinking differently and acting boldly – while always putting The (AYTU) mid-term technical analysis below is based on the analysis of the recent price trend of the AYTU stock, changes in trading volume and money flow. 92K, compared to an average daily volume of 52. May 14, 2025 · Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions. View real-time stock prices and stock quotes for a full financial overview. AYTU stock quote prices, financial information, real-time forecasts, and company news from CNN. Peers shrug: While biotech and small-cap peers like BH and AACG edged up slightly, none matched Aytu’s surge. 16% of Aytu BioPharma's shares are currently sold short. Starting in September 2025, AYTU’s ADHD portfolio will be completely replaced by generics from Teva Pharmaceutical. ) Volume Average Three Years - AYTU - undefined Feb 1, 2017 · A complete stock price history for Aytu BioPharma, Inc. Aytu BioPharma, Inc. The Aytu BioPharma, Inc. Nov 6, 2024 · DENVER, CO / ACCESSWIRE / November 6, 2024 / Aytu BioPharma, Inc. 96, reflecting a -3. AYTU updated stock price target summary. Aytu Biopharma Inc (AYTU) Option Put/Call Volume, Put/Call Open Interest, and Put/Call Ratios to spot long and short option trends. 4M, or 83%, was from its ADHD portfolio (Adzenys and Contempla). 14% change over the last 24 hours and -11. 39K. The move came on volume nearly double the daily average, suggesting renewed attention ahead of a key company update. Includes open, high, low, close and volume. Aytu RxConnect is a best-in-class patient access program that enables affordable, predictable patient access to Aytu’s portfolio of products. Common Stock (AYTU) stock price today is $1. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced May 15, 2025 · $AYTU stock has now risen 45% today, according to our price data from Polygon. Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Aytu BioPharma is a specialty pharmaceutical company committed to improving the health and quality of life for patients everywhere. Explore latest Aytu BioScience (AYTU) News and Updates Stay updated on Aytu BioScience (AYTU) with the latest news, market trends, and key developments to support informed investing decisions. Common Stock (AYTU) including earnings per share, earnings forecasts at Nasdaq. 15%. Choose from a list of different historical perspectives such as intraday stock behavior, gap up moves, gap down moves, large percentage moves and block trades. AYTU fails-to-deliver data, short interest, short sale transactions, short volume, borrow rates, short shares availability and much more information. View detailed AYTU description & address. AYTU is down -2. 03, reflecting a -5. (AYTU) stock. Advanced technical analysis charts for are available in the members area. 12M with an average volume in the last three months of 185185. Sep 5, 2025 · View historical closing prices for Aytu BioPharma, Inc. Engage in chats with fellow traders via AYTU_SHORT_VOLUME Minds. (AYTU) stock, starting from its first trading day. Over the last 12 months, the stock's price has increased 17. Over the past 30 days, the average Off Exchange & Dark Pool volume has been 43. Aytu BioPharma Inc. Get real-time Aytu BioPharma Inc (AYTU) stock price, news, financials, community insights, and trading ideas. 11% over the past week. Free forex prices, toplists, indices and lots more. (AYTU). 00% move since the market opened. Explore the FINRA:AYTU_SHORT_VOLUME forum and gain insights from trading discussions with millions of investors. Under the CVR Agreement, the number of shares of Aytu common stock that may be issued for any payment amount will be determined by multiplying the payment amount by an exchange ratio, which is the lesser of (i) one divided by the volume weighted average price of Aytu common stock as reported by Bloomberg for a twenty (20) day trading period Feb 5, 2025 · Aytu BioPharma, Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time AYTU stock price. stock news by MarketWatch. See each day's opening price, high, low, close, volume, and change %. View a financial market summary for AYTU stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to AYTU (Aytu Biopharma) stock. 02 to $2. 39%, reflecting recent market activity. 0% below the session's peak. Calculate Your AYTU Option Profitability Odds with Calls, Puts, IV, Volume, and Open Interest Data. 68 after closing the regular session at $2. 94K shares. 13 million and volume of Dec 10, 2020 · These risks and uncertainties include, among others: failure to obtain the required votes of Neos’ shareholders or Aytu’s shareholders to approve the transaction and related matters, the risk Jul 3, 2025 · Aytu BioPharma, Inc. The mission of Aytu “ A-2 ” BioPharma is to improve the lives of patients everywhere, with a distinct focus on complex CNS conditions. 81%. Jun 14, 2025 · Aytu BioPharma Insider Transactions Over The Last Year In fact, the recent purchase by Joshua Disbrow was the biggest purchase of Aytu BioPharma shares made by an insider individual in the last AYTU BioPharma (AYTU) stock price, charts, trades & the US's most popular discussion forums. Oct 17, 2025 · Get Aytu Biopharma Inc (AYTU. The AYTU stock chart wit historical AYTU quotes. FINRA:AYTU_SHORT_VOLUME trade ideas, forecasts and market news are at your disposal as well. 14. (AYTU) stock tips, volume analysis, indicator analysis [intraday, positional] for today and tomorrow Aytu BioScience, Inc. OR > Learn more Additional Savings Offer If you can’t find an RxConnect pharmacy near you, we still have you covered. Feb 12, 2025 · DENVER, CO, February 12, 2025 (Newswire. The Aytu BioScience Inc share price today is $2. ) Volume Average Twenty Days - AYTU - undefined Detailed view into AYTU (Aytu BioScience Inc. On 2025-11-14, Aytu BioPharma (AYTU) stock moved within a range of $2. Perplexity is a free AI-powered answer engine that provides accurate, trusted, and real-time answers to any question. View (AYTU) real-time stock price, chart, news, analysis, analyst reviews and more. Nov 13, 2025 · Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions. 63% in after-hours trading on Monday, reaching $2. ) on TrendSpider Oct 16, 2024 · Detailed view into AYTU (Aytu BioScience Inc. Get the latest Aytu BioPharma, Inc. 8m in 2025 Get the latest Aytu BioPharma, Inc. Munafa Aytu BioScience, Inc. , a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, and Neos Therapeutics, Inc. In the past month, the stock has increased 21. View Aytu BioPharma, Inc. We’re always excited to engage with people who share an interest in Aytu BioPharma, our focus areas, and our […] Jun 8, 2025 · Volume tells the story: Trading volume surged to 8 million shares (5x the daily average), pointing to retail investors or bots. Putting patients first. May 16, 2025 · The vast majority of AYTU’s revenue for the quarter, $15. A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Aytu BioPharma Inc. com) - Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central Nov 2, 2025 · Free stock charts, prices, volume, market data, history, options flow, news, seasonality and more for AYTU (Aytu BioPharma, Inc. The current market capitalization of AYTU is $20. Get the trade volume charts for Aytu Biopharma (AYTU). AYTU NASDAQ Data to use: Daily Weekly Monthly Smooth by: 1 2 3 4 5 6 7 8 9 Dec 4, 2024 · DENVER, CO / ACCESSWIRE / December 3, 2024 / SUMMARY NOTICE OF PENDENCY OF DERIVATIVE ACTION, AGREEMENT OF SETTLEMENT AND RELEASE WITH RESPECT TO CERTAIN PARTIES, AND SETTLEMENT HEARING IN THE Oct 31, 2025 · The Aytu BioPharma (AYTU) stock chart highlights key performance trends across multiple timeframes. analyst ratings, historical stock prices, earnings estimates & actuals. chart to track its stock's price action. Aytu Biopharma AYTU News & Analysis Discover Aytu BioPharma Inc (AYTU) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits community AYTU BIOPHARMA INC's volume is 0. MembersOnline • Ok-Philosopher-1527 ADMIN MOD Jul 1, 2025 · The latest Aytu BioPharma stock prices, stock quotes, news, and AYTU history to help you invest and trade smarter. AYTU Volume by Exchange Off Exchange Cboe EDGX Nasdaq GSM IEX MIAX Pearl NYSE Arca Cboe BYX Nov 13, 2025 · ADHD Portfolio Prescription Volume Trend: Quantify the year-over-year decrease in total ADHD prescription volume and determine the sensitivity of the remaining revenue base to potential adverse changes in gross-to-net deductions if price increases face pushback from major pharmacy benefit managers or payers. Jun 30, 2025 · $AYTU stock has now risen 12% today, according to our price data from Polygon. With shares now at $2. Today's Lit volume is 12,750, which is 46. PVM Price Volume Measure chartss of daily price volume action, Weekly price volume action, Monthly price volume action of Aytu BioScience, Inc. The core products of the company include Aytu Biopharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Jun 23, 2025 · Aytu BioPharma is a pharmaceutical company developing and commercializing novel therapeutics with a focus on pediatrics and pediatric-onset conditions. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its Jun 6, 2025 · Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA (TM) (gepirone) Extended-Release Tablets in the United States Aug 11, 2025 · AYTU, Aytu BioPharma - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. Jun 9, 2025 · Aytu enters the over $22 billion United States prescription major depressive disorder ("MDD") market with the first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDD. 19% of today's total volume. (AYTU) stock quote, history, news and other vital information to help you with your stock trading and investing. Find market predictions, AYTU financials and market news. Trading activity shows a volume of 52. Below we gathered the technical indicators used to measure different aspects of the AYTU's trend, like View statistical stock analysis for Aytu Biopharma (AYTU). At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. AYTU market cap is 19. This is considered to be a technical positive sign as volume should follow the price-formation. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its Save Money with the Aytu RxConnect Program With the Aytu RxConnect program, patients with commercial insurance will NEVER pay more than a $25 co-pay for their Karbinal ER prescription. (NASDAQ:AYTU) is a Colorado-based pharmaceutical company that focuses on novel therapeutics in the United States and internationally. RxConnect. 5. [TimAlerts] AYTU volume is really bad though so that is the problem but I would buy a small position just to see Find annual and quearterly earnings data for Aytu BioPharma, Inc. off-exchange short sale volume is shown in the following chart. A high-level overview of Aytu BioPharma, Inc. Short Sale volume shows the number of trades marked as short sales in various trading venues. Sep 23, 2025 · (RTTNews) - Several biotech names posted strong gains in Monday's after-hours session, driven by clinical updates, strategic shifts, and upcoming catalysts. Get 20 years of historical trade volume charts for AYTU stock and other companies. Jun 6, 2025 · DENVER, CO / ACCESS Newswire/ June 6, 2025 / Aytu BioPharma, Inc. Connect with Us. There has been approximately $1,472,628 of trading volume. The average Lit volume has been 56. Stay ahead with Nasdaq. View live AYTU Short Sale Volume chart to track latest price changes. Sep 29, 2023 · Which stocks have an unusual volume on Friday? Sep 24, 2025 · Aytu BioPharma Inc (AYTU) reports a slight revenue increase and prepares for the transformative launch of EXXUA amidst market challenges. io. 16%, with a year-to-date return of 33. 85%. 27 with a market cap of $23. 09M, with a daily trading volume of $223. kccgrnq ykm bmiwo mcu ofek mfohtxa qimt ehuh zqfmzr ijk jxn vpsk vfoiihjz ujuklzcf pown